Medical News

RSS

Survival and health outcomes for extremely preterm infants improve over 20 years

Over the last 20 years, complications have decreased and survival has improved for extremely preterm infants, according to a study in the September 8 issue of JAMA.

9 Sep 2015

Warwick Medical School to lead study on the effect of physiotherapy after breast cancer surgery

What is expected to be the biggest UK study on the effect of physiotherapy on women after breast cancer surgery is to be led by Warwick Medical School in partnership with University Hospitals Coventry and Warwickshire NHS Trust.

9 Sep 2015

Researchers identify new way to help AML patients avoid a relapse

A protein domain once considered of little importance may be key to helping patients who are fighting acute myeloid leukemia (AML) avoid a relapse.

8 Sep 2015

Novel research tool identifies link between negative symptoms of schizophrenia and adverse clinical outcomes

A novel research tool developed by researchers from the Institute of Psychiatry, Psychology & Neuroscience at King's College London has identified a link between the negative symptoms experienced by people with schizophrenia and adverse clinical outcomes.

8 Sep 2015

Molecular evolution in separate species predicts convergence of toxin resistance

Researchers at LSTM have shown that under certain circumstances evolution can be highly predictable, especially in terms of how creatures become resistant to dangerous toxins.

8 Sep 2015

Struggling to live with lung cancer

New data show that more than 50% of patients and carers struggled to cope with challenges of living with lung cancer.

8 Sep 2015

Free online end of life care course

Sheffield Hallam University is teaming up with St Luke's Hospice to launch a free online course supporting health and social care workers in providing palliative or end of life care.

8 Sep 2015

Vernalis Therapeutics announces availability of codeine-based cough and cold syrup in the U.S.

Vernalis Therapeutics Inc., a subsidiary of Vernalis plc, today announced that Tuzistra XR (codeine polistirex and chlorpheniramine polistirex), extended-release oral suspension, CIII (DEA Schedule III) is now available to adult patients and physicians in the United States.

8 Sep 2015

Oxis Biotech executes worldwide license agreement to develop, commercialize novel cancer therapy

Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of an exclusive worldwide license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.

8 Sep 2015

FDA grants Orphan Drug designation to Rigel's Fostamatinib for treatment of patients with ITP

Rigel Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has granted Orphan Drug designation to Fostamatinib, Rigel's oral spleen tyrosine kinase (SYK) inhibitor which is currently in Phase 3 clinical studies in patients with chronic immune thrombocytopenic purpura (ITP).

8 Sep 2015

NanoPass to supply MicronJet600 device for use with Immune Design's ZVex discovery platform

NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.

8 Sep 2015

Mylan releases generic version of Yasmin Tablets in the U.S.

Mylan N.V. today announced the U.S. launch of Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg/0.03 mg, which is the generic version of Bayer's Yasmin Tablets. Mylan's partner Famy Care Ltd. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for use by women to prevent pregnancy.

8 Sep 2015

Al-Hidaya brings Medizone's AsepticSure systems into the Kingdom of Saudi Arabia to reduce MERS-coronavirus

Medizone International, Inc., manufacturers of the AsepticSure Hospital Disinfection System, are pleased to announce the recent sale and delivery of the initial two AsepticSure systems to Al-Hidaya International Medical Services Company headquartered in Jeddah, the Kingdom of Saudi Arabia.

8 Sep 2015

Impax Laboratories receives FDA notice regarding Hayward manufacturing facility

Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.

8 Sep 2015

IRIDEX launches novel intra-ocular pressure monitoring device

IRIDEX Corporation today announced that it has added a novel intra-ocular pressure (IOP) monitoring device called a tonometer to its suite of commercial products for the global glaucoma market. The new device comes to IRIDEX through a distribution agreement with Icare Finland Plc, a subsidiary of the Revenio Group Corporation, the creator of the tonometer.

8 Sep 2015

Why do we sleep? An interview with Professor Wisden

It is true that we still do not know why we need to sleep every night. Sleep is essential for health. We have to do it every day. But nobody yet knows why. This fact amazes me.

8 Sep 2015

Helsinn, BIAL sign exclusive distribution and licence agreement for Anamorelin

Helsinn, the Swiss Group focused on building quality cancer care, and BIAL - Portela & Ca. S.A., one of the largest Iberian pharmaceutical companies, today announce that they have entered into an agreement for the exclusive distribution and licence rights to Anamorelin in Spain, Portugal, Angola and Mozambique.

8 Sep 2015

DCR launches Biospecimen Research Grant Program

DaVita Clinical Research, a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its Biospecimen Research Grant Program (BioReG), a grant program to award clinical-trial-quality biospecimens and annotated de-identified data to academic medical centers involved in kidney research.

8 Sep 2015

Scientists discover mechanism that could lead to new treatment for allergies

Most people with allergies have to take medication throughout their life: Their body "thinks" that proteins from the environment are so "strange" that they elicit an immune reaction. Until present, it was not possible to develop an efficient therapy so that the body "learns" to stop in an overreacting way.

8 Sep 2015

Lund University researchers reveal how the body develops acute pancreatitis

Researchers at Lund University in Sweden may have discovered one of the keys to understanding how the body develops acute pancreatitis. The results offer hope for the development of drugs that specifically target the disease.

8 Sep 2015

Medical News

Survival and health outcomes for extremely preterm infants improve over 20 years

Warwick Medical School to lead study on the effect of physiotherapy after breast cancer surgery

Researchers identify new way to help AML patients avoid a relapse

Novel research tool identifies link between negative symptoms of schizophrenia and adverse clinical outcomes

Molecular evolution in separate species predicts convergence of toxin resistance

Struggling to live with lung cancer

Free online end of life care course

Vernalis Therapeutics announces availability of codeine-based cough and cold syrup in the U.S.

Oxis Biotech executes worldwide license agreement to develop, commercialize novel cancer therapy

FDA grants Orphan Drug designation to Rigel's Fostamatinib for treatment of patients with ITP

NanoPass to supply MicronJet600 device for use with Immune Design's ZVex discovery platform

Mylan releases generic version of Yasmin Tablets in the U.S.

Al-Hidaya brings Medizone's AsepticSure systems into the Kingdom of Saudi Arabia to reduce MERS-coronavirus

Impax Laboratories receives FDA notice regarding Hayward manufacturing facility

IRIDEX launches novel intra-ocular pressure monitoring device

Why do we sleep? An interview with Professor Wisden

Helsinn, BIAL sign exclusive distribution and licence agreement for Anamorelin

DCR launches Biospecimen Research Grant Program

Scientists discover mechanism that could lead to new treatment for allergies

Lund University researchers reveal how the body develops acute pancreatitis

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News